This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Magnesium Sulfate Injection, USP

Starting date:
May 17, 2013
Posting date:
May 28, 2013
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-33697

Recalled Products

  1. Magnesium Sulfate Injection, USP

Reason

Glass particulates discovered during inspection of retention samples (1 of 34 vials).

Depth of distribution

Wholesalers and hospitals across Canada.

Affected products

A. Magnesium Sulfate Injection, USP

DIN, NPN, DIN-HIM
DIN 02139499
Dosage form
  • Solution
Strength
  • 500 mg/mL
Lot or serial number
  • 6103881
Companies
Recalling Firm
Pharmaceutical Partners of Canada Inc.
Suite 200, 45 Vogell Road
Richmond Hill
L4B 3P6
Ontario
CANADA
Marketing Authorization Holder
Pharmaceutical Partners of Canada Inc.
Suite 200, 45 Vogell Road
Richmond Hill
L4B 3P6
Ontario
CANADA

Date modified: